Our Steve Liesman reports the latest regarding the Powell probe while former Dallas Fed President Richard Fisher weighs in on what it means for the Fed and market confidence. Warren Pies of 3Fourteen Research lays out a bold call: upgrade equities, downgrade bonds and stay long oil. The episode also examines how geopolitical tensions are showing up in corporate earnings. Companies like Procter & Gamble warn of rising commodity costs and growing profit pressure tied to global instability. Adam Crisafulli of Vital Knowledge previews what he calls the most important week of earnings and explains what investors should watch. Intel takes focus as a stock of the week. Frank Lee of HSBC explains why he upgraded the name ahead of earnings—and its more than 20% jump higher. Our Angelica Peebles breaks down new GLP-1 prescription data and the growing valuation gap across healthcare as the weight loss drug market continues to evolve.